News Headlines Article

Diabetes patients should not stop taking Avandia, FDA says
USA Today - Rita Rubin

The Food and Drug Administration said Monday that for now, patients should not stop taking the diabetes drug Avandia, subject of a two-year Senate Finance Committee investigation whose findings were revealed Saturday. A May 2007 study in The New England Journal of Medicine raised concerns that Avandia increased users’ heart attack risk. In July 2007, an outside panel of experts convened by the FDA voted 20-3 that Avandia did raise heart attack risk. But the panel voted 22-1 to recommend keeping the drug on the market.